Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3754255012 | 3',5'-cyclic-nucleotide phosphodiesterase inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3754257016 | Substance with 3',5'-cyclic-nucleotide phosphodiesterase inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
3',5'-cyclic-nucleotide phosphodiesterase inhibitor | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | 3',5'-cyclic-nucleotide phosphodiesterase inhibitor | true | Inferred relationship | Some | ||
3',5'-cyclic-nucleotide phosphodiesterase inhibitor | Is a | Substance categorized by disposition | false | Inferred relationship | Some | ||
3',5'-cyclic-nucleotide phosphodiesterase inhibitor | Is a | Hydrolase | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Levosimendan (substance) | Is a | False | 3',5'-cyclic-nucleotide phosphodiesterase inhibitor | Inferred relationship | Some | |
3',5'-cyclic-nucleotide phosphodiesterase inhibitor-containing product | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | True | 3',5'-cyclic-nucleotide phosphodiesterase inhibitor | Inferred relationship | Some | 1 |
This concept is not in any reference sets